AEON Biopharma Incの株価・株式情報
企業概要
AEON Biopharma is a biopharmaceutical company focused on developing its proprietary botulinum toxin complex, ABP-450 (prabotulinumtoxinA) injection (ABP-450), for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. Co. has development and distribution rights for therapeutic indications of ABP-450 in the U.S., Canada, the European Union, the U.K., and certain other international territories. Co. is developing ABP-450 for the preventative treatment of migraine
